Trial · NCT00032591
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to First Event (Death, Stroke, Major Bleed) | Patient Self-Testing (PST) | Cumulative Incidence at 500 Days | 0.0785 | 95% Confidence Interval 0.0645 to 0.0925 | cumulative probability of event |
| Time to First Event (Death, Stroke, Major Bleed) | High Quality Anticoagulation Management (HQACM) | Cumulative Incidence at 500 Days | 0.0987 | 95% Confidence Interval 0.0830 to 0.1144 | cumulative probability of event |
| Time to First Event (Death, Stroke, Major Bleed) | Patient Self-Testing (PST) | Cumulative Incidence at 1000 Days | 0.1542 | 95% Confidence Interval 0.1349 to 0.1734 | cumulative probability of event |
| Time to First Event (Death, Stroke, Major Bleed) | High Quality Anticoagulation Management (HQACM) | Cumulative Incidence at 1000 Days | 0.1820 | 95% Confidence Interval 0.1610 to 0.2031 | cumulative probability of event |
| Time to First Event (Death, Stroke, Major Bleed) | Patient Self-Testing (PST) | Cumulative Incidence at 1500 Days | 0.2268 | 95% Confidence Interval 0.2002 to 0.2535 | cumulative probability of event |
| Time to First Event (Death, Stroke, Major Bleed) | High Quality Anticoagulation Management (HQACM) | Cumulative Incidence at 1500 Days | 0.2524 | 95% Confidence Interval 0.2229 to 0.2818 | cumulative probability of event |
| Time in Therapeutic Range Over Full Length of Follow-up (0 to 100 Percent) | Patient Self-Testing (PST) | 66.2 | Standard Deviation 14.2 | percentage | |
| Time in Therapeutic Range Over Full Length of Follow-up (0 to 100 Percent) | High Quality Anticoagulation Management (HQACM) | 62.4 | Standard Deviation 17.1 | percentage | |
| DASS at 2 Years of Follow-up | Patient Self-Testing (PST) | 46.8 | Standard Deviation 16.3 | score | |
| DASS at 2 Years of Follow-up | High Quality Anticoagulation Management (HQACM) | 49.2 | Standard Deviation 18.0 | score | |
| Cumulative Gain in Health Utilities at 2 Year | Patient Self-Testing (PST) | 1.204 | Standard Deviation 0.619 | score | |
| Cumulative Gain in Health Utilities at 2 Year | High Quality Anticoagulation Management (HQACM) | 1.049 | Standard Deviation 0.575 | score | |
| Health Care Costs at 2 Year | Patient Self-Testing (PST) | 25,754 | Standard Deviation 35,673 | U.S. Dollars | |
| Health Care Costs at 2 Year | High Quality Anticoagulation Management (HQACM) | 24,505 | Standard Deviation 31,827 | U.S. Dollars |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00032591/results